PT Metro Healthcare Indonesia Tbk
Bear Case (25th pct.)
-100.8% vs price
Base Case (Median)
-94.4% vs price
Bull Case (75th pct.)
-92.8% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $-14.70 | -103.6% | High (40%) |
| PE Comparable | $22.59 | -94.4% | Medium (25%) |
| Graham Number | $45.67 | -88.8% | Medium (40%) |
| EV/EBITDA | $29.13 | -92.8% | Medium (20%) |
| Earnings Power Value | $-3.35 | -100.8% | Medium (50%) |
Based on 5 out of 8 methods, CARE.JK appears overvalued at the current price of $406.00. The base case fair value of $22.59 implies 94.4% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.